Dry Eye Treatment Devices

Global Dry Eye Treatment Devices Market to Reach US$970.4 Million by 2030

The global market for Dry Eye Treatment Devices estimated at US$671.9 Million in the year 2024, is expected to reach US$970.4 Million by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Broadband Light, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$426.1 Million by the end of the analysis period. Growth in the Intense Pulsed Light segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$183.1 Million While China is Forecast to Grow at 9.9% CAGR

The Dry Eye Treatment Devices market in the U.S. is estimated at US$183.1 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$199.3 Million by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global "Dry Eye Treatment Devices" Market – Key Trends & Drivers Summarized

Why Is Dry Eye Syndrome Becoming a Widespread Health Concern?

Dry eye syndrome (DES) has become one of the most common ocular surface disorders, affecting millions of individuals worldwide. The increasing prevalence of screen-related eye strain, environmental pollution, and aging populations has led to a sharp rise in cases of chronic dry eye disease (DED). Prolonged exposure to digital screens, particularly with the widespread use of smartphones, computers, and tablets, has resulted in a growing incidence of meibomian gland dysfunction (MGD) and tear film instability. Moreover, autoimmune diseases such as Sjögren’s syndrome, post-LASIK surgery complications, and hormonal imbalances contribute to a significant portion of dry eye cases, necessitating advanced medical device-based treatments to manage symptoms effectively.

What Innovative Devices Are Transforming Dry Eye Treatment?

The Dry Eye Treatment Devices market is witnessing a surge in non-invasive and energy-based solutions aimed at restoring tear film function and improving ocular comfort. Intense Pulsed Light (IPL) therapy, which stimulates meibomian gland function, has gained widespread adoption as a primary treatment for evaporative dry eye disease. Additionally, thermal pulsation systems, radiofrequency therapy, and neurostimulation devices have emerged as effective methods for stimulating tear production, reducing inflammation, and restoring lipid secretion in the tear film. Companies are also investing in wearable tear stimulation devices that use neuromodulation to activate the lacrimal glands, offering an alternative to traditional artificial tear solutions and prescription eye drops.

How Are Market Trends and Healthcare Policies Influencing Growth?

Rising healthcare awareness and increased diagnosis rates of dry eye disease have contributed to growing market demand for innovative treatment devices. Ophthalmologists and optometrists are increasingly adopting in-office dry eye treatments due to their higher success rates compared to conventional lubricating drops and punctal plugs. Additionally, telemedicine advancements have allowed remote monitoring and digital-based diagnostics, enhancing early detection and personalized treatment plans. The integration of AI-driven diagnostic tools in ophthalmology clinics is also improving patient outcomes by enabling more precise dry eye classification and customized treatment protocols.

What Factors Are Driving Market Expansion?

The growth in the Dry Eye Treatment Devices market is primarily driven by the rising prevalence of digital eye strain, increasing demand for non-invasive treatments, and growing awareness of advanced ophthalmic therapies. The aging population, rising incidences of autoimmune-related dry eye disease, and growing R&D investments in ocular health technologies are also key drivers. Additionally, the shift toward home-use dry eye devices, AI-driven diagnostic solutions, and wearable tear stimulation therapies is set to revolutionize the treatment landscape. With strong technological advancements and increasing global accessibility to ophthalmic care, the Dry Eye Treatment Devices market is expected to experience substantial growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Dry Eye Treatment Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Technology (Broadband Light, Intense Pulsed Light, Meibomian Gland Expression, Combination); End-Use (Hospitals, Ophthalmic Clinics, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• AbbVie Inc. (Allergan)
• Akorn Operating Company LLC
• Alcon Inc.
• Alimera Sciences
• Bausch + Lomb Incorporated
• BioTissue, Inc.
• BlephEx LLC
• ESW Vision
• EyePrint Prosthetics, LLC
• GlaxoSmithKline plc
• Holbar Medical Products
• IMED Pharma
• Johnson & Johnson Vision Care, Inc.
• Lumenis Ltd.
• MiBo Medical Group
• Novartis AG
• NuSight Medical
• OASIS Medical
• Oyster Point Pharma, Inc.
• Quantel Medical (Lumibird Medical)

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.